Updates: Lung
3rd ILD Summit Highlights
About the conference : ILD Summit The ILD Summit is a niche industry dedicated conference focussed on advancing therapies for progressive fibrosing interstitial lung diseases (ILD). This year’s conference was the…
Read update
Pulmonary toxicity – a challenge for drug development
Despite the common assumption that adverse drug reactions usually affect the kidney and liver, over 600 medications have been reported to induce lung toxicity.1 Due to ehri large surface area,…
Read update
The inside story of lung in vitro models with Dr Megan Webster
The lung team at Newcells Biotech have developed a Small Airway Epithelial Cell model and an FMT-assay, what are the possible applications of these models for lung research? Â Cellular lung-models…
Read update
Antibody drug conjugates (ADCs) – the role of in vitro models in safety assessment
One the fastest growing approaches to treat cancer is the use of antibody drug conjugates (ADCs). Since the approval of the first antibody drug conjugate in 2000,…
Read update
The latest FMT Assay: An invaluable tool for modelling fibrotic disease
Fibrotic diseases, including liver fibrosis, pulmonary fibrosis, and renal fibrosis, are characterized by the excessive deposition of extracellular matrix (ECM) components, leading to the formation of fibrous tissue that…
Read update
Lung epithelium in vitro modelling of SARS-CoV2 infections to aid Covid-19 treatments
Newcells Biotech’s team has developed a state-of-the-art iPSC-derived in vitro model of the human upper airway to accelerate the development of novel treatments against Covid-19 and other respiratory…
Read update
